You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

radioiodine treatment

Showing 1 - 25 of 194
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Thyroid Carcinoma, Radioactive Iodine Level Trial in Nashville (Artificial Tears)

Recruiting
  • Thyroid Carcinoma
  • Radioactive Iodine Level
  • Artificial Tears
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 25, 2023

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Differentiated Thyroid Cancer Trial in Leiden (rhTSH-stimulated I-124 dosimetry, Intra-therapeutic I-131 dosimetry)

Recruiting
  • Differentiated Thyroid Cancer
  • rhTSH-stimulated I-124 dosimetry
  • Intra-therapeutic I-131 dosimetry
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Apr 8, 2022

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

Differentiated Thyroid Cancer Trial in Beijing (Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive

Recruiting
  • Differentiated Thyroid Cancer
  • Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
  • radioactive iodine
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 28, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Metastatic Thyroid Cancer Trial in Essen (Trametinib 2 MG [Mekinist], Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2)

Recruiting
  • Metastatic Thyroid Cancer
  • Trametinib 2 MG [Mekinist]
  • Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2) [Tafinlar]
  • Essen, Northrhine-Westphalia, Germany
    Manuel M. Weber
May 17, 2022

Thyroid Cancer, Intermediate Risk Trial in France (Systematic RAI-treatment, Decision of RAI-treatment guided by a

Recruiting
  • Thyroid Cancer
  • Intermediate Risk
  • Systematic RAI-treatment
  • Decision of RAI-treatment guided by a post-operative assessment
  • Angers, France
  • +26 more
Jul 26, 2022

Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for

Recruiting
  • Thyroid Gland Follicular Carcinoma
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Differentiated Thyroid Cancer Trial in Beijing (rhTSH, Radioiodine (131I))

Recruiting
  • Differentiated Thyroid Cancer
  • rhTSH
  • Radioiodine (131I)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 11, 2022

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

Low Risk Differentiated Thyroid Cancer Trial in Villejuif (rhTSH stimulation, I131, Follow up)

Active, not recruiting
  • Low Risk Differentiated Thyroid Cancer
  • rhTSH stimulation
  • +2 more
  • Villejuif, Val De Marne, France
    Institut Gustave Roussy
Dec 7, 2021

Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

Recruiting
  • Thyroid Carcinoma
  • +5 more
  • I-124 PET/CT lesion dosimetry
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2022

Efficacy of Lenvatinib in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Cancer
  • Gender
  • Rome, Italy
    Regina Elena National Cancer Institute
Mar 16, 2023

Differentiated Thyroid Cancer Trial in Beijing (Donafenib, Placebo)

Terminated
  • Differentiated Thyroid Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 29, 2021

Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)

Active, not recruiting
  • Thyroid Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

Salivary dysfuncTion After Radioiodine Treatment

Completed
  • Thyroid Cancer
  • Paris, France
    Pitié-Salpêtrière hospital
May 6, 2021

Differentiated Thyroid Cancer in Treatment With Radioiodine

Completed
  • Thyroid Cancer
  • Psycho-oncological Intervention Based on Counselling (PIBC)
  • Torrevieja, Spain
    Hospital Quironsalud Torrevieja
Sep 22, 2021

Quality of Life After Interventional Thyroid Treatment

Completed
  • Thyroid; Deficiency
  • Quality of Life
  • Levothyroxine Sodium
  • Luedenscheid, NRW, Germany
    Department of Nuclear Medicine Klinikum Luedenscheid
Mar 28, 2022

Thyroid Cancer Metastatic Trial in France (Lenvatinib + Denosumab)

Recruiting
  • Thyroid Cancer Metastatic
  • Lenvatinib + Denosumab
  • Angers, France
  • +13 more
Mar 14, 2022

Thyroid Cancer Trial in Boston, New York, Houston (RAD001)

Completed
Has Results
  • Thyroid Cancer
  • Boston, Massachusetts
  • +3 more
Oct 1, 2021

Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)

Active, not recruiting
  • Differentiated Thyroid Cancer (DTC)
  • Poorly Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

Myeloid Cell Reprogramming in Thyroid Carcinoma

Completed
  • Thyroid Cancer
    • Nijmegen, Netherlands
      Radboudumc
    Jan 25, 2022

    Multinodular Goiter Trial in Worldwide (Placebo, MRrhTSH)

    Completed
    • Multinodular Goiter
    • Boston, Massachusetts
    • +10 more
    Jun 3, 2022